On February 1, 2010, the Mongolian Ministry of Health has received 240.000 doses of pandemic H1N1 influenza vaccine, the first batch of total 540.000 doses purchased by the Government of Mongolia. Arepanrix is one of the pandemic vaccines being developed and manufactured by British-based pharmaceutical corporation GlaxoSmithKline, and is the first H1N1 pandemic vaccine to be pre-qualified by the UN body, the World Health Organization.
Further, the second consignment of 200.000 doses will arrive in Mongolia within February followed by the final supply of 100.000 doses in March 2010. The transportation service is being handled by UNOPS, the United Nations Office for Project Services.
As of today, over 100.000 people including health professionals, pregnant women, and people with underlying conditions have already been vaccinated against the pandemic influenza.









Introduction:








